Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 007807/0006 | |
| Pages: | 4 |
| | Recorded: | 11/29/1995 | | |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
1
|
|
Patent #:
|
|
Issue Dt:
|
06/24/1997
|
Application #:
|
08564458
|
Filing Dt:
|
11/29/1995
|
Title:
|
METHOD FOR TREATING RETINAL GANGLION CELL INJURY USING GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR (GDNF) PROTEIN PRODUCT
|
|
Assignee
|
|
|
1840 DEHAVILLAND DRIVE, DEPT. 431, AMGEN CENTER |
THOUSAND OAKS, CALIFORNIA 91320 |
|
Correspondence name and address
|
|
U.S. PATENT OPERATIONS/DRC
|
|
AMGEN INC., DEPT. 431
|
|
DANIEL R. CURRY
|
|
1840 DEHAVILLAND DRIVE
|
|
THOUSAND OAKS, CA 91320-1789
|
Search Results as of:
05/05/2024 03:55 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|